Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Rivella

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Journal of Blood Medicine|March 5, 2015
Recent trends in the gene therapy of β-thalassemiaAlessia Finotti, Laura Breda, Carsten W Lederer, et al.
Cancer Research|March 26, 2014
Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutationsLeenus Martin, Arsen Grigoryan, Ding Wang, et al.
Human Gene Therapy|December 19, 2006
Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapyMichel Sadelain, Farid Boulad, Renzo Galanello, et al.
Blood Advances|September 6, 2023
Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesisRaymond Liang, Miao Lin, Vijay Menon, et al.
International Journal of Molecular Sciences|January 27, 2021
CYP450 Mediates Reactive Oxygen Species Production in a Mouse Model of β-Thalassemia through an Increase in 20-HETE ActivityRayan Bou-Fakhredin, Batoul Dia, Hilda E Ghadieh, et al.
Annals of the New York Academy of Sciences|August 18, 2010
Hepcidin and Hfe in iron overload in beta-thalassemiaSara Gardenghi, Pedro Ramos, Antonia Follenzi, et al.
Kidney International|June 24, 2020
Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney diseaseEdwin Patino, Stephen B Doty, Divya Bhatia, et al.
Drug Discovery Today|September 4, 2022
Emergent treatments for β-thalassemia and orphan drug legislationsEnrico Costa, Maria Domenica Cappellini, Stefano Rivella, et al.
Annals of the New York Academy of Sciences|December 13, 2005
Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?Eliezer A Rachmilewitz, Orly Weizer-Stern, Konstantin Adamsky, et al.
Haematologica|October 5, 2019
Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult β-thalassemia majorCarla Casu, Roberta Chessa, Alison Liu, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Journal of Blood Medicine|March 5, 2015
Recent trends in the gene therapy of β-thalassemiaAlessia Finotti, Laura Breda, Carsten W Lederer, et al.
Cancer Research|March 26, 2014
Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutationsLeenus Martin, Arsen Grigoryan, Ding Wang, et al.
Human Gene Therapy|December 19, 2006
Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapyMichel Sadelain, Farid Boulad, Renzo Galanello, et al.
Blood Advances|September 6, 2023
Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesisRaymond Liang, Miao Lin, Vijay Menon, et al.
International Journal of Molecular Sciences|January 27, 2021
CYP450 Mediates Reactive Oxygen Species Production in a Mouse Model of β-Thalassemia through an Increase in 20-HETE ActivityRayan Bou-Fakhredin, Batoul Dia, Hilda E Ghadieh, et al.
Annals of the New York Academy of Sciences|August 18, 2010
Hepcidin and Hfe in iron overload in beta-thalassemiaSara Gardenghi, Pedro Ramos, Antonia Follenzi, et al.
Kidney International|June 24, 2020
Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney diseaseEdwin Patino, Stephen B Doty, Divya Bhatia, et al.
Drug Discovery Today|September 4, 2022
Emergent treatments for β-thalassemia and orphan drug legislationsEnrico Costa, Maria Domenica Cappellini, Stefano Rivella, et al.
Annals of the New York Academy of Sciences|December 13, 2005
Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?Eliezer A Rachmilewitz, Orly Weizer-Stern, Konstantin Adamsky, et al.
Haematologica|October 5, 2019
Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult β-thalassemia majorCarla Casu, Roberta Chessa, Alison Liu, et al.
Pageof 15